Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Boston Scientific Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $20.07B | $16.75B | $14.24B | $12.68B | $11.89B | $9.91B | $10.73B | $9.82B | $9.05B | $8.39B |
| Revenue Growth? | +19.9% | +17.6% | +12.3% | +6.7% | +19.9% | -7.7% | +9.3% | +8.6% | +7.9% | 0.0% |
| Cost of Revenue? | $6.22B | $6.48B | $5.41B | $4.97B | $4.43B | $4.34B | $3.86B | $3.35B | $3.18B | $3.04B |
| Gross Profit? | $13.85B | $10.27B | $8.83B | $7.71B | $7.46B | $5.58B | $6.88B | $6.48B | $5.87B | $5.34B |
| Gross Margin? | +69.0% | +61.3% | +62.0% | +60.8% | +62.8% | +56.2% | +64.1% | +65.9% | +64.9% | +63.7% |
| Operating Expenses? | $9.88B | $7.63B | $6.65B | $5.89B | $5.54B | $4.97B | $5.17B | $4.74B | $4.35B | $4.11B |
| Operating Income? | $3.97B | $2.63B | $2.18B | $1.82B | $1.92B | $601.00M | $1.71B | $1.74B | $1.52B | $1.24B |
| EBITDA? | $3.73B | $3.94B | $3.45B | $2.74B | $2.52B | $1.51B | $2.21B | $2.58B | $2.01B | $1.23B |
| Income Before Tax | $3.38B | $2.28B | $1.99B | $1.14B | $1.08B | -$79.00M | $687.00M | $1.42B | $933.00M | $177.00M |
| Income Tax Expense | $493.00M | $436.00M | $393.00M | $443.00M | $36.00M | $2.00M | -$4.01B | -$249.00M | $828.00M | -$170.00M |
| Net Income? | $2.89B | $1.85B | $1.59B | $698.00M | $1.04B | -$82.00M | $4.70B | $1.67B | $104.00M | $347.00M |
| EPS? | $1.96 | $1.26 | $1.08 | $0.45 | $0.69 | $-0.08 | $3.38 | $1.21 | $0.08 | $0.26 |
| Diluted EPS? | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 | $-0.08 | $3.33 | $1.19 | $0.07 | $0.25 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality